Basal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Basal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-06-27Clinical Trial Update: Tacrolimus, Nivolumab, and Ipilimumab in Treating Kidney Transplant Recipients With Selected Unresectable or Metastatic Cancers [Phase 1]
Phase 1 trial evaluating the combination of tacrolimus with immune checkpoint inhibitors nivolumab and ipilimumab in kidney transplant recip…
-
CLINICAL_TRIALS trial_result · 2023-04-14Clinical Trial Update: Placebo Microneedles in Healthy Volunteers (Part I) and Efficacy/Safety of Doxorubicin Microneedles in Basal Cell Cancer Subjects (Part II) [Phase 1, Phase 2]
Clinical trial update involving placebo microneedles in healthy volunteers (Part I) and efficacy/safety of doxorubicin microneedles in basal…
-
CLINICAL_TRIALS trial_result · 2023-04-06Clinical Trial Update: Skin Cancer Prevention With Nicotinamide in Transplant Recipients - Pilot Trial [Phase 2]
Pilot phase 2 trial evaluating nicotinamide for prevention of skin cancer in transplant recipients.
-
FDA label_change · 2023-03-27FDA Approved: ERIVEDGE — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for ERIVEDGE (vismodegib) from Genentech, Inc., resulting in labeling changes.
-
CLINICAL_TRIALS trial_result · 2023-01-05Clinical Trial Update: Metvix PDT in Participant With "High Risk" Basal Cell Carcinoma [Phase 3]
Phase 3 trial update for Metvix PDT in high-risk basal cell carcinoma completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-12-14Clinical Trial Update: CellFX Treat & Resect Low-Risk BCC Feasibility Study [NA]
Feasibility study update for CellFX treatment and resection in low-risk basal cell carcinoma completed with posted results in 2022.
-
CLINICAL_TRIALS trial_result · 2022-08-30Clinical Trial Update: Hydrogen Peroxide Trial to Investigate the Efficacy of 30%H2O2 as a Topical Application Before Definitive Treatment [Phase 2]
A Phase 2 clinical trial is investigating the efficacy of 30% hydrogen peroxide topical application before definitive treatment for skin can…
-
CLINICAL_TRIALS trial_result · 2022-08-18Clinical Trial Update: Relationship Between Pharmacokinetics and Safety of Vismodegib - OPTIVISMO-1 [Phase 4]
Phase 4 trial update examining how pharmacokinetics relate to safety signals for vismodegib in basal cell carcinoma patients.
-
CLINICAL_TRIALS trial_result · 2022-08-17Clinical Trial Update: Dose Escalation Trial to Evaluate Dose Limiting Toxicity/Maximum Tolerated Dose of Microneedle Arrays Containing Doxorubicin (D-MNA) in Basal Cell Carcinoma (BCC) [Phase 1]
A Phase 1 dose-escalation trial of microneedle arrays delivering doxorubicin for basal cell carcinoma was terminated; results were posted in…
-
CLINICAL_TRIALS trial_result · 2022-08-04Clinical Trial Update: Tailored Sonidegib Schedule After Complete Response in BCC [Phase 2]
Phase 2 trial update exploring a tailored sonidegib schedule after complete response in locally advanced basal cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2022-07-26Clinical Trial Update: PD-1 in Patients With Advanced Basal Cell Carcinoma Who Experienced Progression of Disease on Hedgehog Pathway Inhibitor Therapy, or Were Intolerant of Prior Hedgehog Pathway Inhibitor Therapy [Phase 2]
Phase 2 study evaluating a PD-1 inhibitor in patients with advanced basal cell carcinoma who progressed on Hedgehog pathway inhibitors or we…
-
CLINICAL_TRIALS trial_result · 2022-03-15Clinical Trial Update: Topical Laser-assisted Combination Chemotherapy for Basal Cell Carcinoma- a Clinical Study [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating topical laser-assisted combination chemotherapy for basal cell carcinoma has completed enrollment with…
-
CLINICAL_TRIALS trial_result · 2022-02-22Clinical Trial Update: Aldara for the Treatment of Large and/or Multiple sBCC [Phase 3]
A Phase 3 trial evaluating Aldara for large or multiple superficial basal cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2022-02-11Clinical Trial Update: Neoadjuvant Vismodegib in Patients With Large and/or Recurrent Resectable Basal Cell Carcinoma [Phase 2]
A Phase 2 neoadjuvant study evaluating vismodegib in patients with large and/or recurrent resectable basal cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2022-02-07Clinical Trial Update: A Study to Evaluate Effectiveness of Imiquimod 5% Cream in Superficial Basal Cell Carcinoma [Phase 3]
Phase 3 trial update evaluating the effectiveness of Imiquimod 5% cream in superficial basal cell carcinoma has completed.
-
CLINICAL_TRIALS trial_result · 2021-10-28Clinical Trial Update: VISmodegib for ORbital and Periocular Basal Cell Carcinoma [Phase 4]
Phase 4 clinical trial update for VISmodegib in orbital and periocular basal cell carcinoma completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-09-16Clinical Trial Update: Calcium Electroporation for Basal Cell Carcinomas - Proof of Concept Study [Phase 3]
Phase 3 proof-of-concept trial exploring calcium electroporation for basal cell carcinoma (captioned as a proof-of-concept study; current st…
-
CLINICAL_TRIALS trial_result · 2020-10-08Clinical Trial Update: A Study of IO103 in Montanide Adjuvant for Basal Cell Carcinoma [Phase 2]
A phase 2 trial evaluating IO103 with Montanide adjuvant for basal cell carcinoma has completed.
-
CLINICAL_TRIALS research · 2020-10-05Clinical Trial Update: Phase II Study of Radiation Therapy and Vismodegib for Advanced Head/Neck Basal Cell Carcinoma [Phase 2]
Phase II study evaluating radiation therapy with vismodegib for locally advanced basal cell carcinoma has completed with results posted.
-
FDA approval · 2020-07-31FDA Approved: ERIVEDGE — Supplemental Application (Genentech, Inc.)
The FDA approved a supplemental application for ERIVEDGE (vismodegib) from Genentech, Inc. to modify or expand its labeling for basal cell c…
-
CLINICAL_TRIALS trial_result · 2019-09-16Clinical Trial Update: Pilot Study of PDL to Treat BCC and SCCIS [NA]
Pilot study update for PDL in treating Basal Cell Carcinoma and Squamous Cell Carcinoma in Situ; study completed with results posted in 2019…
-
CLINICAL_TRIALS trial_result · 2019-09-06Clinical Trial Update: Long-pulsed 1064 nm Nd:YAG Laser Treatment of Basal Cell Carcinoma [NA]
Clinical trial update on long-pulsed 1064 nm Nd:YAG laser treatment for Basal Cell Carcinoma; trial completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-07-31Clinical Trial Update: Vismodegib in Basal Cell Carcinomas (BCC) Chemoprevention [Phase 2]
Phase 2 trial update for vismodegib in basal cell carcinomas has been terminated.
-
CLINICAL_TRIALS trial_result · 2019-07-05Clinical Trial Update: Strategies to Promote Skin Health [NA]
A completed clinical trial update focusing on strategies to promote skin health; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-06-06Clinical Trial Update: STEVIE: A Study of Vismodegib in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma [Phase 2]
Phase 2 trial update for vismodegib in locally advanced or metastatic basal cell carcinoma completed with posted results.